Old Web
English
Sign In
Acemap
>
authorDetail
>
Simin K. Baygani
Simin K. Baygani
Eli Lilly and Company
Medicine
Internal medicine
Adverse effect
Lasmiditan
Incidence (epidemiology)
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study.
2021
Pulmonary circulation
D. Dunbar Ivy
Damien Bonnet
Rolf M.F. Berger
Gisela M B Meyer
Simin K. Baygani
Baohui Li
Show All
Source
Cite
Save
Citations (0)
Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain.
2021
Current Medical Research and Opinion
Mario Fernando Prieto Peres
Raghavendra Vasudeva
Simin K. Baygani
Ellen B. Dennehy
Maurice Vincent
Deborah I. Friedman
Show All
Source
Cite
Save
Citations (1)
Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review
2021
Journal of Perinatology
Heike Rabe
Varsha Bhatt-Mehta
Stephen Bremner
Aisling Ahluwalia
Renske Mcfarlane
Simin K. Baygani
Beau Batton
Agnes Klein
Ebru Ergenekon
Luana Pesco Koplowitz
Eugene M. Dempsey
Dina Apele-Freimane
Hiroko Iwami
Janis M. Dionne
Show All
Source
Cite
Save
Citations (0)
Tolerability and Safety of Lasmiditan Treatment in Elderly Patients With Migraine: Post Hoc Analyses From Randomized Studies.
2021
Clinical Therapeutics
Vincent T. Martin
Zubair Ahmed
Helen Hochstetler
Simin K. Baygani
Yan Dong
Paula M. Hauck
Rashna Khanna
Show All
Source
Cite
Save
Citations (1)
1